According to the IPO, Entomatic Aurora Medical Technology Co., Ltd. (hereinafter referred to as “Aurorax”) formally filed a prospectus with the Hong Kong Stock Exchange on 8 August 2023, proposing to be listed on the Main Board, with China Corporation and Pujin International acting as joint sponsors.
Founded in 2012, Cerebral Aurora is the first company in China to combine brain science and artificial intelligence technology to develop medical-grade digital therapy products for dementia, and is also the highest-grossing commercialization company for medical-grade dementia digital therapy products in the Chinese market in 2022.
To date, CBT's digital therapy product pipeline covers assessments and interventions for a wide range of dementias — among which, CBT's core product system has been commercialized for eight indications, and an additional 21 for dementia are under development, including atrial fibrillation, hypertension, coronary heart disease, Cognitive disorders caused by Parkinson's disease, anxiety, delayed language development, cerebral palsy, dyslexia, epilepsy, and diabetes.
Specifically, the core product system of Brain-Powered Aurora is an evidence-based medical-grade digital therapy product for cognitive impairment and the first digital therapy product in China to receive regulatory approval — combining clinical experience in brain science with deep neural network algorithms to assess patient conditions and FOR PERSONALIZED DIGITAL THERAPY TREATMENT.
The underlying layer of this system contains the two fundamental technologies of brain-powered aurorae, virtual human technology and AI technology — virtual human technology can simultaneously evaluate large numbers of patients, greatly improving the...

Lotus Technology Inc., a leading manufacturer of luxury electric vehicles under Geely in Hubei, China, entered into a business merger agreement with L Catterton Asia Acquisition Corp. (LCAA) on January 31, 2023 with the NASDAQ SPAC (Special Purpose Acquisition Company) is expected to complete the listing on NASDAQ within the year, and the stock symbol will be changed to LOT in the future.
The transaction was valued at US$5.4 billion. After the transaction, all existing shareholders of Luteus, including Geely Holdings, Etika Automotive and Weilai Capital expect to hold approximately 89.7% of the combined company in the future.
Stay tuned for more information
Headquartered in Hubei, China, Luteus Technology is a luxury electric vehicle manufacturer, develops and manufactures luxury electric living cars (SUV, four-door coupe), with operations in China, the UK and the European Union.
The era of new energy is getting closer to us, and whether future trends become the latest leaders, we are welcome to discuss.

Market news: “Good Health” under the banner of Gao Chi will be formally filed with the Hong Kong Stock Exchange in the third quarter as soon as the third quarter is expected to be listed in the Hong Kong Main Board IPO.
Earlier, Bloomberg reported that the Gaozi Health Plan launched its fastest IPO in Hong Kong in the second half of the year, with plans to raise more than US$5 million. Its IPO advisory team may include US Dollar, Goldman Sachs and Haitong International.
GAOCHI HEALTH, AS A MEDICAL MAJOR HEALTH INDUSTRY GROUP FOCUSED ON STRATEGIC INVESTMENTS AND OPERATIONS IN THE MAJOR HEALTH SECTOR, PRIMARILY BY PROVIDING PRODUCTS AND SERVICES DRIVEN BY THE “MEDICAL+DRUG+HEALTH MANAGEMENT” TRICORE, PROVIDING PATIENTS WITH HEALTH SCREENING, DISEASE PREVENTION, RECURRENCE, SLOW DISEASE MANAGEMENT, PATIENT EDUCATION, MEDICINE A one-stop disease and health management solution at the heart of casework, general practitioner services. GAOCHI MEDICAL, WHICH CURRENTLY OWNS MORE THAN 60 DRUG STORE BRANDS AND OPERATES MORE THAN ONE MILLION PHYSICAL STORES IN MORE THAN 20 PROVINCES ACROSS THE COUNTRY.
Sky Survey data showed that Takao held 94.76% of the shares in Gaoqi Health and 5.24% in Emerging Wealth Asset Management.
Stay tuned for more information！